Skip to main content

Advertisement

Figure 4 | Thrombosis Journal

Figure 4

From: Recombinant human soluble thrombomodulin administration improves sepsis-induced disseminated intravascular coagulation and mortality: a retrospective cohort study

Figure 4

Adjusted estimated survival curves by the covariate of AKI in Cox regression models. The solid line represents patients in the treatment group, and the dotted line represents patients in the control group. Treatment with rhTM was associated with a significantly higher rate of survival (P = 0.026 by Cox regression analysis). AKI, acute kidney injury; rhTM, recombinant human soluble thrombomodulin.

Back to article page